Clinical stage medical device company shaping the future of LAA occlusion with the CLAAS implant for non-valvular AF patients. #shapingLAAclosure
Nashua, NH
Joined March 2021
- Tweets126
- Following103
- Followers160
- Likes40
W. L. GORE & ASSOCIATES TO ACQUIRE CONFORMAL MEDICAL, EXPANDING ITS PRESENCE IN ENDOVASCULAR TREATMENTS prn.to/4sImbMX
RIO 2025 kicks off this week! Join FREE this Friday, November 21 at 4:30 PM EST for an exciting Case & Discussion: Next-Generation LAAC – Precision Closure with Foam and Flexibility Presented by Dr. Devi G Nair, MD, FACC, FHRS
Register now: qrco.de/bgSzM3
Join us at #HRS2025 this Friday, April 25 in San Diego!
SDCC, Exhibit Hall | 🕐 1–3 PM PT
GLACE Trial: ICE-Guided Implantation of a 2nd Gen Foam-Based LAA Occluder (PO-02-189)
Presented by Dr. Shephal Doshi
#Cardiology #LAAO #EP
Big News from Conformal Medical!
Early results from our GLACE Study will be presented @ the Annual AF Symposium in Boston Friday 17, 2025.
Over 30 patients worldwide have been treated with the new CLAAS AcuFORM LAAO device in the CONFORM IDE Trial and the European GLACE Study.
ALT https://www.prnewswire.com/news-releases/conformal-medical-announces-glace-study-to-be-highlighted-at-af-symposium-302352589.html
#TCT2024 attendees, don't miss out!
@ 9:50am join Dr. William Gray for the “The Next-Gen CLAAS® AcuFORM™ LAAO Technology: Program Update” during the TCT Innovation 16: Innovations in LAAO Technologies session
Room: Innovation Theater, (Halls A-C), Lower Level
#TCT2024 attendees, don’t miss the opportunity to see the CLAAS AcuFORM System in action.
Today @ 11:50am join Professor Nielsen-Kudsk, M.D. as he reviews a live case presentation with the CLAAS® AcuFORM™ LAAO System.
Room: Structural Spotlight Room (Halls D-E), Level 2
#TCT2024, Kicks off today @ the Walter E. Washington Convention Center in Washington, D.C.!
Don’t miss this opportunity to explore the latest in LAAO techniques and technologies.
See you there!
tct2024.crfconferences.com/p…
Join us at #TCT2024 next week to explore the next-gen CLAAS AcuFORM System in two exclusive LAAO sessions.
Discover the latest advancements and hear firsthand insights from two industry leaders shaping the future of LAAO procedures.
conformalmedical.com/company…
The Conformal next-generation CLAAS® AcuFORM™ Left Atrial Appendage Occlusion (LAAO) System will be highlighted in several sessions during the 2024 #TCT2024 conference in Washington, DC, October 27-30th.
"Simplified sizing and ease of use enabled by this device will drive improved workflow in the lab." prn.to/3zOPDKf
Today we announced the initiation of the GLACE Study. This European study* aims to assess ICE imaging of the LAA during appendage closure procedures with the next-generation CLAAS® AcuFORM™ device in patients with non-valvular atrial fibrillation. prnewswire.com/news-releases…
#NYVALVES2024 attendees, grab a coffee and join @AVKaplanMD, tomorrow morning, Wed, June 5th, for his presentation on Early Feasibility Studies: How to Enable Innovation While Maintaining Safety.
It's going to be an informative & insightful session you won't want to miss!
Meet with the Conformal team at #NYVALVES2024 summit this week to learn how we are developing the next generation LAAO technology that conforms to a range of anatomies, enabling clinicians to simplify the procedure with only 2 sizes, and confirm seal with angiography.
New York Valves kicks off next week in New York. This summit is an excellent opportunity to learn and explore structural heart therapies including Left Atrial Appendage Closure (LAAC).
We look forward to seeing you at New York Valves!
Today, we announce the CLAAS® System was featured in a podium presentation at the Cardiovascular Research Technologies (CRT) 2024 conference.
See the link for the press release below.
conformalmedical.com/company…
ALT Conformal Medical’s CLAAS® System Demonstrates Low Thrombogenicity Compared to Commercially Available LAAO Devices
#CRT2024!
Join us today, at 10:39 AM, with @AVKaplanMD , as he discusses "Conformal: Design and Clinical Data on a Novel LAA Closure Device." Gain insights into a revolutionary LAA closure device's meticulous design and clinical outcomes.
Join us at 5:00 PM starting today at #CRT2024.
William Gray, MD., will present "the Conformal Self-Adaptable LAA Closure Device: Initial Clinical Experience."
Tomorrow, at 3:24 PM; dive deep into comparative thrombogenicity with William Gray, MD.
ALT CRT2024 LAAO Technology
Join Conformal and Industry leaders at #CRT2024 this weekend for cutting-edge insights and advances in the Cardiovascular industry.
Take advantage of the opportunities to learn about new technology in development designed to advance #LAAO therapy.
ALT On Saturday 9, at 5:00 PM: Explore the future with William Gray, MD., as he presents Conformal Self-Adaptable LAA Closure Device: Initial Clinical Experience." Take this chance to be at the forefront of innovative cardiovascular solutions. Then, on Sunday 10, at 3:24 PM, Dive deep into comparative thrombogenicity with William Gray, MD., as he presents "Comparative Acute Thrombogenicity Of The CLAAS Foam Implant And Watchman FLX In An In Vitro Blood Loop Model." Finally, on Tuesday, 13, at 10:39 AM, Aaron Kaplan, MD, will discuss "Conformal: Design and Clinical Data on a Novel LAA Closure Device." Gain insights into a revolutionary LAA closure device's meticulous design and clinical outcomes.
This past week, the Conformal Medical team had an opportunity to get together to celebrate! Visit the Conformal website to learn more about the company and how we are advancing the science of LAAO: conformalmedical.com/company…
#Cardiology #LAAO #data #conformalmedical #claas #Afib
Congratulations to @bojodaddy and the exceptional Cardiovascular Research Team with the University at @KaleidaHealth for their successful implantation and trial enrollment of the CLAAS® device.
Visit the Conformal website to learn more conformalmedical.com/company…
#Cardio #Afib
